Journal of Cell Biology 2007-05-21

Zinc is a novel intracellular second messenger.

Satoru Yamasaki, Kumiko Sakata-Sogawa, Aiko Hasegawa, Tomoyuki Suzuki, Koki Kabu, Emi Sato, Tomohiro Kurosaki, Susumu Yamashita, Makio Tokunaga, Keigo Nishida, Toshio Hirano

Index: J. Cell Biol. 177 , 637-45, (2007)

Full Text: HTML

Abstract

Zinc is an essential trace element required for enzymatic activity and for maintaining the conformation of many transcription factors; thus, zinc homeostasis is tightly regulated. Although zinc affects several signaling molecules and may act as a neurotransmitter, it remains unknown whether zinc acts as an intracellular second messenger capable of transducing extracellular stimuli into intracellular signaling events. In this study, we report that the cross-linking of the high affinity immunoglobin E receptor (Fcepsilon receptor I [FcepsilonRI]) induced a release of free zinc from the perinuclear area, including the endoplasmic reticulum in mast cells, a phenomenon we call the zinc wave. The zinc wave was dependent on calcium influx and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase activation. The results suggest that the zinc wave is involved in intracellular signaling events, at least in part by modulating the duration and strength of FcepsilonRI-mediated signaling. Collectively, our findings indicate that zinc is a novel intracellular second messenger.


Related Compounds

  • AMMONIUM TET...

Related Articles:

Ion-pair chromatography coupled to inductively coupled plasma-mass spectrometry (IPC-ICP-MS) as a method for thiomolybdate speciation in natural waters.

2015-03-17

[Anal. Chem. 87(6) , 3388-95, (2015)]

Potentiation of antibiofilm activity of amphotericin B by superoxide dismutase inhibition.

2013-01-01

[Oxid. Med. Cell. Longev. 2013 , 704654, (2013)]

Regio- and stereospecific synthesis of beta-sulfonamidodisulfides and beta-sulfonamidosulfides from aziridines using tetrathiomolybdate as a sulfur transfer reagent.

2007-03-16

[J. Org. Chem. 72 , 2106, (2007)]

Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.

2005-05-01

[Curr. Cancer Drug Targets 5 , 195, (2005)]

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C.

2012-01-01

[BMC Cancer 12 , 147, (2012)]

More Articles...